Peter Hohenberger, MD, is Head of the Division of Surgical Oncology and Thoracic Surgery at the Medical Faculty Mannheim, University of Heidelberg. He is a boarded surgeon in visceral and vascular surgery as well as in thoracic surgery and surgical intensive care. He got his professional education at the University of Erlangen and was trained in psychology and pathology. His surgical qualifications were received at the University of Heidelberg.
He has held senior positions at the Department of Surgery, University of Heidelberg as well as at Charité, Berlin. He is a surgical oncologist now specializing in the treatment of GIST and soft tissue tumors and is the Past-Chairman of the EORTC Soft Tissue and Bone Sarcoma Group. He is a collaborator to the EORTC organisation (GI, melanoma and STBSG) since the 1980s and has been a member of the Protocol Review Committee as well as to the Board of EORTC for nine years each. His center has participated in major multinational randomized studies on the treatment of GIST and sarcoma. Trial activities also include the EU-funded EUROSARC and CONTICANET consortia. MITIGATE is a most recently started research network pursuing the treatment of imatinib-resistant GIST. He served on the faculty of the AACR/ASCO/FECS course on Methods of Clinical Cancer Research for seven years and is also member to the advisory board of SPAGN (Sarcoma Patients Euronet), Das LEBENSHAUS and was one of the initiators of SOS-DESMOID. In addition, the Mannheim center hosts the German Interdisciplinary Sarcoma Group (GISG).
